HANMI PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322,000 KRW | +1.74% |
|
+0.94% | -8.65% |
| May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
| May. 01 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HANMI PHARM. CO., LTD. | Generic Pharmaceuticals | +1.74% | +0.94% | -8.65% | +9.12% | -13.18% | 3.03B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A128940 Stock
- Charts Hanmi Pharm. Co., Ltd.
- Comparison Chart
